Inverness Counsel LLC Pfizer Inc Transaction History

Inverness Counsel LLC

$1.8 Billion
Q3 2022

A detailed history of Inverness Counsel LLC transactions in Pfizer Inc stock. As of the latest transaction made, Inverness Counsel LLC holds 19,406 shares of PFE stock, worth $545,114. This represents 0.05% of its overall portfolio holdings.

Number of Shares

19,406

Previous 18,606 4.3%

Holding current value

$545,114

Previous $976,000 13.01%

% of portfolio

0.05%

Previous 0.05%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 26, 2022	BUY	$43.76 - $53.42 $35,008 - $42,736	800 Added 4.3%	19,406 $849,000
Q2 2022 Jul 20, 2022	BUY	$46.53 - $55.17 $23,358 - $27,695	502 Added 2.77%	18,606 $976,000
Q1 2022 May 05, 2022	SELL	$45.75 - $56.69 $91,362 - $113,209	-1,997 Reduced 9.93%	18,104 $937,000
Q4 2021 Feb 07, 2022	SELL	$41.32 - $61.25 $86,317 - $127,951	-2,089 Reduced 9.41%	20,101 $1.19 Million
Q3 2021 Nov 02, 2021	SELL	$39.25 - $50.42 $27,475 - $35,294	-700 Reduced 3.06%	22,190 $954,000
Q2 2021 Aug 10, 2021	SELL	$35.91 - $40.68 $76,847 - $87,055	-2,140 Reduced 8.55%	22,890 $896,000
Q1 2021 May 04, 2021	SELL	$33.49 - $37.77 $68,654 - $77,428	-2,050 Reduced 7.57%	25,030 $907,000
Q4 2020 Jan 27, 2021	SELL	$33.47 - $42.56 $52,849 - $67,202	-1,579 Reduced 5.51%	27,080 $997,000
Q2 2020 Aug 10, 2020	SELL	$30.12 - $36.54 $54,667 - $66,320	-1,815 Reduced 5.96%	28,659 $937,000
Q1 2020 May 05, 2020	SELL	$27.03 - $38.62 $27,084 - $38,697	-1,002 Reduced 3.18%	30,474 $995,000
Q4 2019 Feb 05, 2020	SELL	$32.92 - $37.36 $1,646 - $1,868	-50 Reduced 0.16%	31,476 $1.23 Million
Q3 2019 Nov 12, 2019	SELL	$32.49 - $42.13 $76,286 - $98,921	-2,348 Reduced 6.93%	31,526 $1.13 Million
Q2 2019 Aug 07, 2019	SELL	$36.98 - $41.52 $143,778 - $161,429	-3,888 Reduced 10.3%	33,874 $1.47 Million
Q1 2019 May 09, 2019	SELL	$37.5 - $41.2 $162,187 - $178,190	-4,325 Reduced 10.28%	37,762 $1.6 Million
Q4 2018 Jan 29, 2019	SELL	$38.47 - $43.86 $22,812 - $26,008	-593 Reduced 1.39%	42,087 $1.74 Million
Q3 2018 Oct 30, 2018	BUY	$34.47 - $41.81 $25,990 - $31,524	754 Added 1.8%	42,680 $1.88 Million
Q2 2018 Aug 02, 2018	SELL	$32.98 - $35.16 $93,630 - $99,819	-2,839 Reduced 6.34%	41,926 $1.52 Million
Q1 2018 May 02, 2018	BUY	$31.91 - $37.02 $141,425 - $164,072	4,432 Added 10.99%	44,765 $1.59 Million
Q4 2017 Feb 02, 2018	SELL	$33.26 - $35.29 $313,641 - $332,784	-9,430 Reduced 18.95%	40,333 $1.46 Million
Q3 2017 Oct 17, 2017	BUY	$31.0 - $34.15 $1.54 Million - $1.7 Million	49,763	49,763 $1.78 Million

Others Institutions Holding PFE

# of Institutions

3,240

Shares Held

3.72B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $158B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Inverness Counsel LLC , based on Form 13F filings with the SEC.

News

Stay updated on Inverness Counsel LLC with notifications on news.

Account

Inverness Counsel LLC Pfizer Inc Transaction History